Founded in Uruguay in 1978, Quanam is a multi-Latin federation of firms specializing in consulting and management, professional services, communication and change management. Priding itself on innovation and knowledge, Quanam’s broad range of clients vary from banking and government agencies to financial institutions and even genetic laboratories.
Quanam, partnering with GenLives, had the goal of allowing clinicians to make more accurate diagnoses in shorter timeframes. Quanam needed a way to isolate the information responsible for causing pathogenic conditions. Geneticists also had to sift through millions of existing academic papers manually, trying to identify these conditions.
For this goal to become a reality, Quanam needed a big data platform that could withstand demanding storage and computing requirements to process multiple complex algorithms. With HDP, the company could analyze and store large volumes of data, and offered a foundation on which machine learning algorithms could be run.
Clinical geneticists can now make more informed decisions on the dangers of genome variants. DNA sequencing now takes a matter of hours, rather than an entire day. This results in a faster diagnosis, from an average of 5 years, down to 8-10 weeks.